Commercial Considerations For Cell And Gene Therapies: Viewpoints From The 2016 ARM Meeting
Executive Summary
There are still many lessons to be learned in commercializing cell and gene therapies. Experts in the industry discussed challenges and best practices at the Alliance for Regenerative Medicine's annual meeting in October.